Sacituzumab Govitecan

Therapeutic Sacituzumab Govitecan ADC from the original Trodelvy® commercial drug.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price
Trop-2-directed ADC
Antibody-drug conjugate (ADC)
Trodelvy®
10 mg/mL
4 mg
-80°C
05/2024
265,00 
view product
Max: 10
Min: 2
Step: 1

Not looking for Sacituzumab Govitecan?

Search our therapeutic molecules product database

Evidentic Support
+49 (0) 30 959 99 8831

Let us know about your inquiry details and we’ll contact you shortly.

we are recruiting